BTRC and diabetic kidney disease: The expression of CK1δ and β-TRCP decreased and YAP was highly expressed in DKD in vivo. MSC-sEV increased the levels of CK1δ and β-TRCP and inhibited YAP, as indicated by immunohistochemical results (Fig. 6G and H).